Rehabilitation of patients with primary breast cancer: assessing the impact of adjuvant therapy.
Ganz
P A
PA
Department of Medicine, UCLA-San Fernando Valley Program, VAMC, Sepulveda 91343.
Polinsky
M L
ML
Schag
C A
CA
Heinrich
R L
RL
D000328:Adult; D000342:Affective Symptoms; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000534:rehabilitation*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008408:Mastectomy / Q000523:psychology; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life; D012959:Socioeconomic Factors; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
D013629:Tamoxifen; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate